Oppenheimer Notes a Solid Q4 for Life Technologies (LIFE), Appropriately Conservative Outlook
Tweet
Share
E-mailGet Alerts LIFE Hot Sheet
Price: $34.02 -2.24%
Rating Summary:
15 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
15 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer commented on Outperform-rated Life Technologies (NASDAQ: LIFE) following solid Q4 results and a conservative 2012 outlook.
The firm notes the company posted slightly better than expected Q4 results led by strong consumable revenue, Ion Torrent placements, and strength in Forensics. The company also provided "achievable" 2012 guidance that calls for revenue growth of 2-4%, EPS of $3.90-4.05 and FCF of $650-675M.
As the company continues to deleverage, management reaffirmed their commitment to disciplined capital deployment through buybacks and targeted acquisitions.
Oppenheimer's analyst said their long-term outlook remains unchanged, as they see substantial opportunity in the Ion Torrent and pending launch of the Ion Proton as well as continued expansion into emerging markets.
Full-year revenue estimate for 2012 remains unchanged at $3.82B while EPS estimate moves to $3.98 from $4.10.
For an analyst ratings summary and ratings history on Life Technologies click here. For more ratings news on Life Technologies click here.
Shares of Life Technologies closed at $48.88 yesterday.
The firm notes the company posted slightly better than expected Q4 results led by strong consumable revenue, Ion Torrent placements, and strength in Forensics. The company also provided "achievable" 2012 guidance that calls for revenue growth of 2-4%, EPS of $3.90-4.05 and FCF of $650-675M.
As the company continues to deleverage, management reaffirmed their commitment to disciplined capital deployment through buybacks and targeted acquisitions.
Oppenheimer's analyst said their long-term outlook remains unchanged, as they see substantial opportunity in the Ion Torrent and pending launch of the Ion Proton as well as continued expansion into emerging markets.
Full-year revenue estimate for 2012 remains unchanged at $3.82B while EPS estimate moves to $3.98 from $4.10.
For an analyst ratings summary and ratings history on Life Technologies click here. For more ratings news on Life Technologies click here.
Shares of Life Technologies closed at $48.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ethos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every Family
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
